Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification

Varan, AliÖzyar, EnisGültekin, M.Çorapcıoğlu, FundaKöksal, YavuzAydın, BurçaAkyüz, CananBüyükpamukçu, Münevver2020-03-262020-03-2620080732-183Xhttps://dx.doi.org/10.1200/jco.2008.26.15_suppl.21003https://hdl.handle.net/20.500.12395/22559[Abstract not Available]en10.1200/jco.2008.26.15_suppl.21003info:eu-repo/semantics/closedAccessPediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantificationConference Object2615WOS:000208457403733Q1